Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 25,000 shares at $26.84 ($671K) on 2015-06-08, disclosed to the SEC on 2015-06-09.
Scheduled sale ($671k) by Vice President, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ITCI | SELL | 2014-10-10 | $71K | — | Filing → |
| ITCI | SELL | 2014-10-07 | $247K | — | Filing → |
| ITCI | SELL | 2014-09-17 | $75K | — | Filing → |